Home / People / DoubleBlindWhat Psilocybin Might Offer That SSRIs Don’tDoubleBlindMon, May 5 Perspectives This week in the Drop In: A new psilocybin vs SSRI analysis, AI’s role in psychedelic therapy, the RFK/Trump psych agenda, and a wellness influencer now in prison. Read all the tea here 🍵: https://t.co/Y5CSfM9opA6472Here’s how psilocybin-assisted therapy and traditional antidepressants affect our brain’s response to joy, surprise, and emotional nuance, according to science.Read More Discover DoubleBlindNewsCannabisPsychedelicsAddictionDispensaryHealthOpioidsScience